Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-25-026207
Filing Date
2025-08-12
Accepted
2025-08-12 16:17:13
Documents
73
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20250630_10q.htm   iXBRL 10-Q 862652
2 EXHIBIT 3.1 ex_849527.htm EX-3.1 2762
3 EXHIBIT 31.1 ex_846656.htm EX-31.1 12818
4 EXHIBIT 31.2 ex_846657.htm EX-31.2 12910
5 EXHIBIT 32.1 ex_846658.htm EX-32.1 5073
6 EXHIBIT 32.2 ex_846659.htm EX-32.2 5138
12 divpipeimg.jpg GRAPHIC 33330
13 noticeofarts_page1.jpg GRAPHIC 173305
14 noticeofarts_page2.jpg GRAPHIC 210346
15 noticeofarts_page3.jpg GRAPHIC 75852
  Complete submission text file 0001437749-25-026207.txt   5300241

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20250630.xsd EX-101.SCH 44229
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20250630_def.xml EX-101.DEF 299900
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20250630_lab.xml EX-101.LAB 233875
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20250630_pre.xml EX-101.PRE 328267
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20250630_cal.xml EX-101.CAL 34900
76 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20250630_10q_htm.xml XML 668207
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 251206961
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)